162184-58-9 Usage
Explanation
The compound's name describes its structure and stereochemistry.
Explanation
The compound has two rings, which are fused together.
Explanation
The compound contains a nitrogen atom, making it an azabicycle.
Explanation
The presence of a nitrogen atom in the bicyclic structure classifies it as an azabicycle.
Explanation
This indicates the specific arrangement of atoms in space, describing the three-dimensional configuration of the compound.
Explanation
The compound serves as a starting point or building block for creating more complex organic molecules.
Explanation
Due to its unique structure and properties, the compound may have various applications in different fields, such as drug development, agriculture, and material development.
Explanation
The compound's utility and characteristics will depend on the particular situation and how it is used within the field of organic chemistry.
Bicyclic Structure
Contains two rings
Nitrogen Atom
Present in the structure
Azabicyclo Compound
Classified as such due to the presence of nitrogen
Stereochemistry
(1S,5R)-designation
Building Block
Used in organic synthesis
Potential Applications
Pharmaceuticals, agrochemicals, and materials science
Context-Dependent
Uses and properties vary based on specific context and application
Check Digit Verification of cas no
The CAS Registry Mumber 162184-58-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,1,8 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 162184-58:
(8*1)+(7*6)+(6*2)+(5*1)+(4*8)+(3*4)+(2*5)+(1*8)=129
129 % 10 = 9
So 162184-58-9 is a valid CAS Registry Number.
162184-58-9Relevant articles and documents
Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: Potential application for the treatment of irritable bowel syndrome
Mitch, Charles H.,Brown, Thomas J.,Bymaster, Frank P.,Calligaro, David O.,Dieckman, Donna,Merrit, Leander,Peters, Steven C.,Quimby, Steven J.,Shannon, Harlan E.,Shipley, Lisa A.,Ward, John S.,Hansen, Kristian,Olesen, Preben H.,Sauerberg, Per,Sheardown, Malcolm J.,Swedberg, Michael D. B.,Suzdak, Peter,Greenwood, Beverley
, p. 538 - 546 (2007/10/03)
Irritable bowel syndrome (IBS) is a pathophysiolocal condition characterized by abnormal bowel habits that are frequently accompanied by abdominal pain. Current therapy based on reducing high-amplitude GI contractions with nonselective muscarinic antagoni